Issue 2, 2024

Carboxymethylcellulose modified Fe3O4@SiO2@GdPO4:Tb3+,Ce3+ nanocomposites for combined optical and magnetic fluid hyperthermia in cancer therapy

Abstract

A stepwise synthetic method is reported for the synthesis of multifunctional, magnetic and luminescent composites with silica-coated Fe3O4 as the core and Ce3+ sensitized Tb3+ doped GdPO4 embedded in carboxymethylcellulose. The phase composition, infrared spectra, luminescence and magnetic properties were characterized by X-ray diffraction, FTIR, photoluminescence spectroscopy and vibrating sample magnetometry, respectively. The synthesized materials exhibit high saturation magnetization and excellent luminescence properties. The composites show intense green emission at 545 nm upon excitation at 276 nm. They attain the hyperthermia temperature (∼42 °C) within the threshold alternating magnetic field (5 × 106 kA m−1 s−1). The samples exhibit efficient induction heating properties which is highly desirable for magnetic hyperthermia application in cancer therapy. The materials are found to have excellent biocompatibility towards the MDA-231 breast cancer cell line and A549 lung cancer cell line with their in vitro cell viability showing 50% and 90%, respectively, for up to 200 μg mL−1 concentration, and the IC50 values reaching 154.33 ± 18.06 μg mL−1 and 667.45 ± 20.03 μg mL−1, respectively. The synthesized multifunctional magnetic luminescent nanocomposites provide a new insight for optical imaging and therapeutic agents for hyperthermia cancer therapy.

Graphical abstract: Carboxymethylcellulose modified Fe3O4@SiO2@GdPO4:Tb3+,Ce3+ nanocomposites for combined optical and magnetic fluid hyperthermia in cancer therapy

Article information

Article type
Paper
Submitted
03 Nov. 2023
Accepted
27 Nov. 2023
First published
27 Nov. 2023
This article is Open Access
Creative Commons BY-NC license

RSC Appl. Interfaces, 2024,1, 313-322

Carboxymethylcellulose modified Fe3O4@SiO2@GdPO4:Tb3+,Ce3+ nanocomposites for combined optical and magnetic fluid hyperthermia in cancer therapy

D. D. Yengkhom, G. S. Ningombam, R. Heisnam, N. Sharma, R. S. Nongmaithem and F. A. S. Chipem, RSC Appl. Interfaces, 2024, 1, 313 DOI: 10.1039/D3LF00217A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements